Similarly, in another study, a multicomponent drug conjugate comprising of an antibody against the breast cancer specific antigen, the human epidermal growth factor receptor 2 (HER2), zinc phthalocyanine, and PEGylated AuNP was synthesized for treating breast cancer cells [80]. Here, ERBB2 is linked to breast cancer.